This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
14 Jun 2011

FDA Publishes Draft Guidance on Nanotechnology

Nanotechnology is an emerging technology with a broad range of potential applications, such as increasing bioavailability of a drug, improving food packaging and in cosmetics.

The US FDA has published a draft guidance on its current thinking on whether regulated products contain nanomaterials or involve the application of nanotechnology. Nanotechnology is an emerging technology with a broad range of potential applications, such as increasing bioavailability of a drug, improving food packaging and in cosmetics.

 

The draft guidance, Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology, is intended for manufacturers, suppliers, importers and other stakeholders. It is available online and open for public comment and represents the first step toward providing regulatory clarity on the FDA's approach to nanotechnology.

 

The FDA has not so far established

Related News